ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Update

ICU Medical, Inc. (NASDAQ:ICUI) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 838,100 shares, a growth of 14.0% from the December 15th total of 735,400 shares. Currently, 3.7% of the company’s shares are sold short. Based on an average daily volume of 217,900 shares, the days-to-cover ratio is currently 3.8 days.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ICUI shares. KeyCorp boosted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Finally, Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $199.67.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director David C. Greenberg sold 972 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now owns 5,037 shares in the company, valued at $796,400.07. The trade was a 16.18 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 29,737 shares of company stock worth $4,941,832 in the last ninety days. 6.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On ICU Medical

Several institutional investors have recently bought and sold shares of the company. Allworth Financial LP boosted its stake in shares of ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Xponance Inc. grew its holdings in shares of ICU Medical by 6.0% during the second quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock worth $235,000 after buying an additional 112 shares in the last quarter. Equitable Trust Co. grew its holdings in shares of ICU Medical by 2.2% during the third quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock worth $950,000 after buying an additional 112 shares in the last quarter. Hexagon Capital Partners LLC raised its position in shares of ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 122 shares during the last quarter. Finally, Connable Office Inc. boosted its position in ICU Medical by 6.4% during the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier’s stock worth $370,000 after acquiring an additional 122 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Trading Down 1.3 %

Shares of ICUI traded down $2.20 during mid-day trading on Friday, reaching $163.87. The company had a trading volume of 219,172 shares, compared to its average volume of 180,890. ICU Medical has a 52-week low of $86.80 and a 52-week high of $196.26. The stock has a 50 day moving average of $161.73 and a two-hundred day moving average of $159.16. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.